BlackRock Inc. - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 66 filers reported holding AQUESTIVE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 16.03 and the average weighting 1.5%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$734,351
+9.5%
479,968
+18.1%
0.00%
Q2 2023$670,399
+63.5%
406,302
+13.0%
0.00%
Q1 2023$410,010
+27.1%
359,658
+0.5%
0.00%
Q4 2022$322,695
-26.2%
357,715
-4.3%
0.00%
Q3 2022$437,000
+84.4%
373,878
+0.6%
0.00%
Q2 2022$237,000
-75.9%
371,716
-1.3%
0.00%
Q1 2022$983,000
-27.4%
376,517
+8.1%
0.00%
Q4 2021$1,354,000
-6.2%
348,366
+5.3%
0.00%
Q3 2021$1,443,000
+3.5%
330,946
-5.7%
0.00%
Q2 2021$1,394,000
-80.2%
351,014
-74.1%
0.00%
Q1 2021$7,054,000
+1.0%
1,356,400
+3.9%
0.00%
Q4 2020$6,985,000
+13.3%
1,305,838
+2.8%
0.00%
Q3 2020$6,166,000
-11.0%
1,270,074
-10.9%
0.00%
Q2 2020$6,929,000
+1396.5%
1,425,806
+574.3%
0.00%
Q1 2020$463,000
-61.1%
211,462
+3.5%
0.00%
Q4 2019$1,189,000
+0.8%
204,245
-44.9%
0.00%
Q3 2019$1,179,000
-26.5%
370,718
-2.9%
0.00%
Q2 2019$1,603,000
-71.1%
381,671
-52.4%
0.00%
Q1 2019$5,539,000
+37.0%
801,756
+24.9%
0.00%
Q4 2018$4,042,000
-51.0%
641,800
+36.1%
0.00%
Q3 2018$8,254,000471,4040.00%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 9,810,958$16,188,081100.00%
Vahanian & Associates Financial Planning Inc. 725,208$1,196,5933.78%
Bracebridge Capital, LLC 428,571$707,1420.39%
Latash Investments, LLC 243,134$401,1710.32%
XTX Topco Ltd 138,145$227,9390.04%
ARMISTICE CAPITAL, LLC 1,158,000$1,910,7000.03%
OCCUDO QUANTITATIVE STRATEGIES LP 84,355$139,1860.01%
Hillsdale Investment Management Inc. 66,600$109,8900.01%
D.B. Root & Company, LLC 12,950$21,3680.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 147,856$243,9620.01%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders